13 | Sigma-1 ReceptorIBA
01/2022
-
12/2008 |
12 | Bee Venoms (Bee Venom)IBA
09/2018
-
02/2001 |
11 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2021
-
06/2006 |
9 | N-Methylaspartate (NMDA)IBA
12/2021
-
02/2010 |
8 | N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA
01/2022
-
06/2006 |
8 | CarrageenanIBA
09/2018
-
03/2008 |
7 | 2- (4- morpholino)ethyl- 1- phenylcyclohexane- 1- carboxylateIBA
01/2022
-
11/2008 |
7 | Formaldehyde (Formol)FDA Link
01/2018
-
03/2003 |
6 | Analgesics (Analgesic Drugs)IBA
12/2021
-
02/2001 |
6 | Adrenergic Receptors (Adrenergic Receptor)IBA
05/2016
-
11/2011 |
5 | EnzymesIBA
10/2019
-
01/2019 |
5 | Serine (L-Serine)FDA Link
01/2019
-
10/2015 |
5 | Clonidine (ST 155)FDA LinkGeneric
05/2016
-
08/2008 |
4 | Dehydroepiandrosterone (DHEA)IBA
01/2022
-
06/2009 |
4 | p38 Mitogen-Activated Protein KinasesIBA
10/2019
-
09/2013 |
4 | CytochromesIBA
10/2019
-
01/2019 |
4 | NeurosteroidsIBA
10/2019
-
06/2009 |
3 | Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
11/2019
-
12/2016 |
3 | Ketoconazole (Nizoral)FDA LinkGeneric
10/2019
-
01/2019 |
3 | SB 203580IBA
10/2019
-
04/2014 |
3 | Proteins (Proteins, Gene)FDA Link
08/2019
-
01/2014 |
3 | 7-nitroindazoleIBA
01/2019
-
08/2011 |
3 | Capsaicin (Zostrix)FDA Link
02/2018
-
07/2008 |
3 | Purinergic P2Y1 ReceptorsIBA
01/2017
-
01/2014 |
3 | Adenosine Triphosphate (ATP)IBA
01/2014
-
08/2010 |
3 | ZymosanIBA
10/2008
-
07/2005 |
3 | Freund's AdjuvantIBA
10/2008
-
02/2001 |
3 | CatecholaminesIBA
10/2007
-
09/2005 |
2 | CalciumIBA
01/2022
-
08/2011 |
2 | Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
12/2021
-
01/2017 |
2 | Protein Isoforms (Isoforms)IBA
11/2019
-
06/2010 |
2 | serine racemaseIBA
01/2019
-
01/2017 |
2 | Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2019
-
01/2017 |
2 | fluorocitrateIBA
01/2019
-
12/2016 |
2 | Mitogen-Activated Protein KinasesIBA
01/2017
-
04/2014 |
2 | Connexin 43 (Connexin43)IBA
01/2017
-
12/2016 |
2 | 2- iodo- N(6)- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA
01/2017
-
04/2014 |
2 | NADPH Oxidase 2IBA
12/2016
-
08/2013 |
2 | CarbenoxoloneIBA
12/2016
-
07/2010 |
2 | acetovanillone (apocynin)IBA
12/2016
-
08/2013 |
2 | Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2016
-
03/2016 |
2 | Therapeutic UsesIBA
01/2013
-
02/2001 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
-
10/2008 |
2 | Evans Blue (Blue, Evans)FDA Link
01/2012
-
10/2008 |
2 | Pharmaceutical PreparationsIBA
03/2011
-
08/2008 |
2 | BicucullineIBA
11/2010
-
06/2009 |
2 | GABA-A Receptor AntagonistsIBA
11/2010
-
06/2009 |
2 | Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
02/2010
-
08/2008 |
2 | CollagenIBA
06/2006
-
06/2006 |
2 | Opioid Analgesics (Opioids)IBA
01/2006
-
08/2004 |
1 | ProgesteroneFDA LinkGeneric
01/2022 |
1 | 2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA
11/2019 |
1 | Messenger RNA (mRNA)IBA
08/2019 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2019 |
1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2019 |
1 | 7-chlorokynurenic acidIBA
01/2019 |
1 | Aminoglutethimide (Cytadren)FDA Link
01/2019 |
1 | LigandsIBA
01/2019 |
1 | Oxidoreductases (Dehydrogenase)IBA
01/2019 |
1 | Protein Kinase CIBA
01/2019 |
1 | Dizocilpine Maleate (Dizocilpine)IBA
01/2019 |
1 | trilostaneFDA Link
01/2019 |
1 | linsidomineIBA
01/2019 |
1 | resiniferatoxinIBA
02/2018 |
1 | Nitroglycerin (Dynamite)FDA LinkGeneric
02/2018 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2018 |
1 | Aromatase (CYP19)IBA
01/2018 |
1 | serine O-sulfateIBA
01/2017 |
1 | InterleukinsIBA
01/2017 |
1 | 2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
01/2017 |
1 | PotassiumIBA
01/2017 |
1 | D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
01/2017 |